|
Total
n=194
|
Total
n=194
|
Favipiravir
n(%)=101(52.1)
|
HQ
n(%)=93(47.9)
|
|
p-value*
|
Baseline HR, bpm |
89±12 |
89±12 |
89±12 |
90±11 |
|
0.64 |
Baseline PR, ms |
151±15 |
151±15 |
151±14 |
150±15 |
|
0.63 |
Baseline QTc, ms |
402±20 |
402±20 |
400±21 |
404±20 |
|
0.14 |
Final HR, bpm |
78±14 |
78±14 |
73±16 |
82±12 |
|
<0.001 |
Final PR, ms |
161±20 |
161±20 |
162±19 |
159±20 |
|
0.21 |
Final QTc, ms |
417±27 |
417±27 |
413±23 |
421±31 |
|
0.04 |
ΔHR, bpm |
8 (-8—70) |
8 (-8—70) |
12 (-6—70) |
5 (-8—41) |
|
<0.001 |
ΔPR, ms |
8 (-11—77) |
8 (-11—77) |
9 (-11—77) |
7
(-8—50) |
|
0.08 |
ΔQTc, ms |
12 (-9—103) |
12 (-9—103) |
11 (-9—57) |
12 (-7—103) |
|
0.59 |
Arrhythmias, n (%) |
32 (16.4) |
32 (16.4) |
20 (19.8) |
13 (13.9) |
|
0.42 |
Sinus bradycardia |
16 (8.2) |
16 (8.2) |
13 (12.9) |
3 (3.2) |
|
0.01 |
First-degree AV block |
3 (1.5) |
3 (1.5) |
1 (1) |
2 (2.2) |
|
0.51 |
Third-degree AV block |
Third-degree AV block |
5
(2.6) |
4 (4) |
1 (1.1) |
|
0.37 |
Nonsustained VT |
Nonsustained VT |
2 (1) |
0 (0) |
2
(2) |
|
0.49 |
QTc prolongation |
QTc prolongation |
12 (6.2) |
3 (3) |
9 (9.7) |
|
0.04 |